Cargando…
Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of motor neurons in adults, with a median survival of 3–5 years after appearance of symptoms, and with no curative treatment currently available. Frontotemporal dementia (FTD) is also an adult-onset neurodegenerative d...
Autores principales: | García-García, Raquel, Martín-Herrero, Laura, Blanca-Pariente, Laura, Pérez-Cabello, Jesús, Roodveldt, Cintia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707599/ https://www.ncbi.nlm.nih.gov/pubmed/34948077 http://dx.doi.org/10.3390/ijms222413280 |
Ejemplares similares
-
Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Yunusova, Yana, et al.
Publicado: (2016) -
Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Iridoy, Marina Oaia, et al.
Publicado: (2018) -
Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry
por: Mesaros, Maysen, et al.
Publicado: (2021) -
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023) -
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
por: Williams, Kelly L., et al.
Publicado: (2016)